Successful reperfusion of an infarct-related coronary artery by primary percutaneous
intervention or fibrinolysis during acute ST-elevation myocardial infarction (STEMI) does not …

Pericytes contract during myocardial ischemia resulting in capillary constriction and no
reflow. Reversing pericyte contraction pharmacologically reduces no reflow and infarct size …

The “no reflow” phenomenon, where the coronary artery is patent after treatment of acute
myocardial infarction (AMI) but tissue perfusion is not restored, is associated with worse …

Thrombosis and distal embolization play crucial role in the etiology of no-reflow. CHA2DS2-
VASc score is used to estimate the risk of thromboembolism in patients with atrial fibrillation …

Background The ratio of serum C‐reactive protein (CRP) to albumin has been proven to be
a more accurate indicator than albumin and CRP levels alone in determining the prognosis …

Objectives In the present study, we analysed the incidence of no-reflow phenomenon, its
clinical and procedural predictors, and associated in-hospital outcomes for the patients …

Myocardial infarction (MI) eventually exacerbates inflammatory response due to the release
of inflammatory and pro-inflammatory factors. The aim of this study is to explore the …

With growing evidence in clinical practice, the understanding of coronary syndromes has
gradually evolved out of focusing on the well-established link between stenosis of epicardial …

Objective—MAPKs (mitogen-activated protein kinases), especially p38, play detrimental
roles in cardiac diseases and cardiac remodeling post-myocardial infarction. However, the …

Rationale: The treatment of microvascular obstruction (MVO) using ultrasound-targeted LNP
cavitation (UTC) therapy mechanically relieves the physical obstruction in the …